DNA Biomed (Israel) Technical Analysis
DNA Stock | ILS 88.80 6.50 6.82% |
As of the 23rd of April, DNA Biomed owns the Coefficient Of Variation of 987.01, market risk adjusted performance of (0.21), and Downside Deviation of 3.21. DNA Biomed Solns technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for DNA Biomed, which can be compared to its peers in the sector. Please confirm DNA Biomed Solns jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if DNA Biomed Solns is priced favorably, providing market reflects its prevailing price of 88.8 per share.
DNA Biomed Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as DNA, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DNADNA |
DNA Biomed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
DNA Biomed Solns Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of DNA Biomed Solns volatility. High ATR values indicate high volatility, and low values indicate low volatility.
DNA Biomed Solns Trend Analysis
Use this graph to draw trend lines for DNA Biomed Solns. You can use it to identify possible trend reversals for DNA Biomed as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual DNA Biomed price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.DNA Biomed Best Fit Change Line
The following chart estimates an ordinary least squares regression model for DNA Biomed Solns applied against its price change over selected period. The best fit line has a slop of 0.32 , which means DNA Biomed Solns will continue generating value for investors. It has 122 observation points and a regression sum of squares at 3944.0, which is the sum of squared deviations for the predicted DNA Biomed price change compared to its average price change.About DNA Biomed Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of DNA Biomed Solns on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of DNA Biomed Solns based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on DNA Biomed Solns price pattern first instead of the macroeconomic environment surrounding DNA Biomed Solns. By analyzing DNA Biomed's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of DNA Biomed's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to DNA Biomed specific price patterns or momentum indicators. Please read more on our technical analysis page.
DNA Biomed April 23, 2024 Technical Indicators
Most technical analysis of DNA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for DNA from various momentum indicators to cycle indicators. When you analyze DNA charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.071 | |||
Market Risk Adjusted Performance | (0.21) | |||
Mean Deviation | 2.69 | |||
Semi Deviation | 2.47 | |||
Downside Deviation | 3.21 | |||
Coefficient Of Variation | 987.01 | |||
Standard Deviation | 4.32 | |||
Variance | 18.7 | |||
Information Ratio | 0.0807 | |||
Jensen Alpha | 0.5791 | |||
Total Risk Alpha | (0.13) | |||
Sortino Ratio | 0.1088 | |||
Treynor Ratio | (0.22) | |||
Maximum Drawdown | 28.65 | |||
Value At Risk | (4.93) | |||
Potential Upside | 7.35 | |||
Downside Variance | 10.28 | |||
Semi Variance | 6.1 | |||
Expected Short fall | (3.43) | |||
Skewness | 2.26 | |||
Kurtosis | 10.12 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNA Biomed Solns. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the DNA Biomed Solns information on this page should be used as a complementary analysis to other DNA Biomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for DNA Stock analysis
When running DNA Biomed's price analysis, check to measure DNA Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Biomed is operating at the current time. Most of DNA Biomed's value examination focuses on studying past and present price action to predict the probability of DNA Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Biomed's price. Additionally, you may evaluate how the addition of DNA Biomed to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |